Professor Per Artursson is the director of UDOPP. His main scientific contribution to UDOPP is expertise in profiling of compound libraries in silico and hit selection in vitro in order to ensure that compound ADMET properties are consistent with obtaining efficacy in vivo.

Pawel Baranczewski PhD in genetic toxicology (University of Bremen, Germany). Over 14 years of experience from pharmaceutical industry (i.e. Pharmacia, AstraZeneca). Expertise in drug discovery and development, drug metabolism and pharmacokinetics (DMPK), physiologically based pharmacokinetics (PBPK) and project management.

Anders Eneroth MSc in biology  (Stockholm University, Sweden). He has over 20 years of experience from pharmaceutical industry (i.e. AstraZeneca, Medivir). Expertise in drug discovery, cell based methods and project management.

Annika Lindqvist PhD in pharmacokinetics (Uppsala University, Sweden). Experience within academic drug discovery. Expertise in drug discovery, bioanalysis, pharmacokinetics, and PKPD modelling (pharmacokinetics/pharmacodynamics).

Maria Mastej BSc in chemistry (Jagielonian University in Cracov, Poland). Over 20 years of experience from pharmaceutical industry. Maria has expertise in cell culturing and cell-based assays.

Aljona Saleh PhD in analytical chemistry (Stockholm University, Sweden). Experience within academic drug discovery. Expertise in drug discovery, bioanalysis (small molecules and biopharmaceuticals), mass spectrometry (MS), in vitro ADME (absorption, distribution, metabolism, excretion), pharmacokinetics (PK) and project management.

Ivailo Simoff, PhD in molecular and cell biology (Stockholm University, Sweden). More than 15 years’ experience in molecular biology. Expertise in in vitro ADME, cell and molecular biology.

Richard Svensson PhD in biochemistry (Karolinska Institutet, Sweden). More than 9 years, experience from pharmaceutical industry (Biovitrum AB). Expertise in drug discovery, in vitro ADME (absorption, distribution, metabolism, and excretion), drug metabolism and pharmacokinetics (DMPK), mass spectrometry (MS), physiologically based pharmacokinetics (PBPK) and project management.

Christine Wegler PhD in pharmaceutical sciences (Uppsala University, Sweden). Expertise in targeted and global proteomics, intracellular drug bioavailability and mass spectrometry.

Jimmy Ytterberg PhD in proteomics and plant biology (Cornell University, Ithaca, NY, USA). Expertise in high resolution mass spectrometry, proteomics, protein characterization and quantification.More than three years, experience from pharmaceutical industry (SOBI AB).